Stockreport

Roivant Sciences Reports Financial Results for the Quarter Ended September 30, 2021 and Provides Business Update

Roivant Sciences Ltd.  (ROIV) 
PDF Roivant began trading on Nasdaq under “ROIV”; cash balance increased to $2.5 billion.Dermavant announced final results from the Phase 3 PSOARING 3 long-term extension st [Read more]